All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
The GvHD Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
Introducing
Now you can personalise
your GvHD Hub experience!
Bookmark content to read later
Select your specific areas of interest
View content recommended for you
Find out moreThe GvHD Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the GvHD Hub cannot guarantee the accuracy of translated content. The GvHD Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
Do we see differences after cord blood transplantation between European and Japanese patients?
Bookmark this article
During the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the GvHD Hub spoke to Junya Kanda, Kyoto University, Kyoto, JP. We asked, Do we see differences after cord blood transplantation between European and Japanese patients?
Do we see differences after cord blood transplantation between European and Japanese patients?
In this video, Kanda discusses the results of the Eurocord/EBMT Acute Leukemia Working Party and JSHCT/JDCHCT (Japan Society and Data Center for Hematopoietic Cell Transplantation) collaborative study. The impact of GvHD on single cord blood transplantation outcomes was evaluated in Japanese and European populations.
Related articles
Newsletter
Subscribe to get the best content related to GvHD delivered to your inbox